Multiple cross-reactive self-ligands for Borrelia burgdorferi-specific HLA-DR4-restricted T cells. 2000

B Maier, and M Molinger, and A P Cope, and L Fugger, and J Schneider-Mergener, and G Sønderstrup, and T Kamradt, and A Kramer
Deutsches Rheumaforschungszentrum Berlin, Germany.

T cell recognition of self antigens is a key event in the pathogenesis of autoimmune diseases. To date, the initial events that trigger autoreactive T cells are unknown. The "molecular mimicry" hypothesis predicts that during an infection T cells that recognize both a microbial antigen and a related self peptide become activated and cause autoimmune disease. We have systematically examined the recognition of self antigens by HLA-DR4-restricted T cells specific for peptides of the outer surface protein A (OspA) of Borrelia burgdorferi, the etiological agent of Lyme disease. We used the peptide spot synthesis technique for complete peptide substitution analyses of two immunodominant OspA epitopes. Each amino acid residue of the epitopes was substituted with all 20 naturally occurring amino acids and the altered peptides were tested for recognition by a panel of OspA-specific T cells. The binding motifs (supertopes) revealed by these analyses were used to screen public databases for matching human or murine peptides. Several hundred peptides were identified by this search and synthesized. Of these, 28 were recognized by OspA-specific T cells. Thus, T cell cross-reactivity is a common phenomenon and the existence of cross-reactive epitopes alone does not imply molecular mimicry-mediated pathology and autoimmunity.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D015748 Borrelia burgdorferi Group Gram-negative helical bacteria, in the genus BORRELIA, that are the etiologic agents of LYME DISEASE. The group comprises many specific species including Borrelia afzelii, Borellia garinii, and BORRELIA BURGDORFERI proper. These spirochetes are generally transmitted by several species of ixodid ticks. Borrelia afzelii,Borrelia burgdorferi sensu lato,Borrelia garinii,Borreliella afzelii,Borreliella garinii
D015804 HLA-DR4 Antigen An HLA-DR antigen which is associated with HLA-DRB1 CHAINS encoded by DRB1*04 alleles. HLA-DR4,Antigen, HLA-DR4,HLA DR4 Antigen
D016056 Immunodominant Epitopes Subunits of the antigenic determinant that are most easily recognized by the immune system and thus most influence the specificity of the induced antibody. Antigenic Determinants, Immunodominant,Antigens, Immunodominant,Epitopes, Immunodominant,Immunodominant Determinant,Immunodominant Domain,Immunodominant Epitope,Immunodominant Region,Immunodominant Site,Immunodominant Determinants,Immunodominant Domains,Immunodominant Regions,Immunodominant Sites,Determinant, Immunodominant,Determinants, Immunodominant,Determinants, Immunodominant Antigenic,Domain, Immunodominant,Domains, Immunodominant,Epitope, Immunodominant,Immunodominant Antigenic Determinants,Immunodominant Antigens,Region, Immunodominant,Regions, Immunodominant,Site, Immunodominant,Sites, Immunodominant

Related Publications

B Maier, and M Molinger, and A P Cope, and L Fugger, and J Schneider-Mergener, and G Sønderstrup, and T Kamradt, and A Kramer
March 1992, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
B Maier, and M Molinger, and A P Cope, and L Fugger, and J Schneider-Mergener, and G Sønderstrup, and T Kamradt, and A Kramer
January 1993, Diagnostic microbiology and infectious disease,
B Maier, and M Molinger, and A P Cope, and L Fugger, and J Schneider-Mergener, and G Sønderstrup, and T Kamradt, and A Kramer
September 2009, Blood,
B Maier, and M Molinger, and A P Cope, and L Fugger, and J Schneider-Mergener, and G Sønderstrup, and T Kamradt, and A Kramer
June 2009, Vaccine,
B Maier, and M Molinger, and A P Cope, and L Fugger, and J Schneider-Mergener, and G Sønderstrup, and T Kamradt, and A Kramer
July 2015, Clinical and vaccine immunology : CVI,
B Maier, and M Molinger, and A P Cope, and L Fugger, and J Schneider-Mergener, and G Sønderstrup, and T Kamradt, and A Kramer
December 1983, The Journal of experimental medicine,
B Maier, and M Molinger, and A P Cope, and L Fugger, and J Schneider-Mergener, and G Sønderstrup, and T Kamradt, and A Kramer
April 2005, Nihon rinsho. Japanese journal of clinical medicine,
B Maier, and M Molinger, and A P Cope, and L Fugger, and J Schneider-Mergener, and G Sønderstrup, and T Kamradt, and A Kramer
May 2019, European journal of immunology,
B Maier, and M Molinger, and A P Cope, and L Fugger, and J Schneider-Mergener, and G Sønderstrup, and T Kamradt, and A Kramer
December 2008, Arthritis and rheumatism,
B Maier, and M Molinger, and A P Cope, and L Fugger, and J Schneider-Mergener, and G Sønderstrup, and T Kamradt, and A Kramer
January 2000, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!